Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Alder Biopharmaceuticals
ALDR

Buy Alder Biopharmaceuticals (ALDR) Stock

ALDR
See ALDR stock price and Buy/Sell Alder Biopharmaceuticals with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
ALDR

Alder Biopharmaceuticals (ALDR)

About Alder Biopharmaceuticals (ALDR)

Alder's mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. Alder plays two roles: As a biopharmaceutical company, Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. The work being done at Alder today will help those who suffer from cancer, autoimmune di...Read more
Market Cap
$1.58B
1 Year High
$19.12
Volume
1 Year Low
$8.39
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch ALDR stock

Alder Biopharmaceuticals Stock News

Alder Biopharmaceuticals stock rating

What analysts recommend for ALDR stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
3

Alder Biopharmaceuticals price target

What analysts think ALDR will be worth
Low $0
High $19.12
Current $0
Target $18

Alder Biopharmaceuticals earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.22
-0.45
-0.67
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020

Expected EPS
Q4 2020
-$0.50
Actual EPS
Q4 2020

Buy Alder Biopharmaceuticals (ALDR) Stock

ALDR
See ALDR stock price and Buy/Sell Alder Biopharmaceuticals with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch ALDR stock
  • bud1971 avatar
  • tbell1125 avatar
  • jenniemac72 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.